Scarica l'app Stockscreener
4.02
0.00%
0.00
Dopo l'orario di chiusura:
4.03
0.01
+0.25%
Precedente Chiudi:
$4.02
Aprire:
$3.925
Volume 24 ore:
11,368
Relative Volume:
0.03
Capitalizzazione di mercato:
$4.69M
Reddito:
$1,000
Utile/perdita netta:
$-11.39M
Rapporto P/E:
-0.1309
EPS:
-30.7182
Flusso di cassa netto:
$-7.26M
1 W Prestazione:
-11.26%
1M Prestazione:
-11.26%
6M Prestazione:
-46.74%
1 anno Prestazione:
-87.53%
Intervallo 1D:
$3.90
$4.05
Intervallo di 1 settimana:
$3.90
$4.83
Portata 52W:
$3.1829
$71.50
Ernexa Therapeutics Inc Stock (ERNA) Company Profile
Nome
Ernexa Therapeutics Inc
Settore
Industria
Telefono
(617) 798-6700
Indirizzo
1035 CAMBRIDGE STREET, CAMBRIDGE
Compare ERNA vs VRTX, REGN, ARGX, MRNA, RVMD
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ERNA
Ernexa Therapeutics Inc
|
4.02 | 4.69M | 1,000 | -11.39M | -7.26M | -30.72 |
VRTX
Vertex Pharmaceuticals Inc
|
514.56 | 132.08B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
793.26 | 83.15B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
984.04 | 62.71B | 4.16B | 1.29B | 734.26M | 19.58 |
MRNA
Moderna Inc
|
136.62 | 54.14B | 2.23B | -3.19B | -1.60B | -8.1462 |
RVMD
Revolution Medicines Inc
|
203.35 | 44.51B | 742.00K | -1.37B | -1.07B | -7.0731 |
Ernexa Therapeutics Inc Borsa (ERNA) Ultime notizie
Price to earnings forward of Ernexa Therapeutics Inc. – NASDAQ:ERNAW - TradingView
Enterprise value to EBIT forward of Ernexa Therapeutics Inc. – NASDAQ:ERNAW - TradingView
Enterprise value to revenue forward of Ernexa Therapeutics Inc. – NASDAQ:ERNAW - TradingView
ERNA Stock Surged 60% Today – Here’s Why Retail Is Buzzing About Ernexa’s Ovarian Cancer Trial Results - Stocktwits
Should I Buy ERNA? ERNA 2026 AnalysisIntellectia AI™ - Intellectia AI
Director takes 2026 cash pay in options at Ernexa (ERNA) - Stock Titan
Ernexa Therapeutics (ERNA) director granted options in place of cash fees - Stock Titan
Ernexa Therapeutics (ERNA) grants director 5,944-share option - Stock Titan
Ernexa Therapeutics Inc. (ERNA) grants CEO 118,848 options expiring 2036 - Stock Titan
Ernexa (NASDAQ: ERNA) pays director with $4.57 stock options - Stock Titan
Ernexa Therapeutics (ERNA) grants director 5,943 stock options at $4.57 - Stock Titan
Eterna Therapeutics Inc (NASDAQ: ERNA) Share Price, ERNA Stock News, ERNA Share Price & Updates - Kalkine
Ernexa Therapeutics : Initial Statement of Beneficial Ownership (Form 3) - marketscreener.com
Ernexa (NASDAQ: ERNA) director’s warrant set to lapse after Phase 1 data - Stock Titan
Ernexa Therapeutics Participates in the Virtual Investor "Why Now" On-Demand Conference - Yahoo Finance
Ernexa (ERNA) Earnings Reading: Reported EPS Misses Expectations at the Close; Closing Move: The Market Price Advances 3.60%Free Cash Flow Trends - vinanet.vn
Ernexa (ERNA) Quarterly Results: Reported EPS Misses Expectations in the Current Update; Post-Report: The Share Price Adds 4.68% on the DayEBITDA Analysis - vinanet.vn
ERNA Stock Shoots Up 140% in a Month: Here's What You Should Know - qz.com
Ernexa Therapeutics Warrants (ERNAW) Hold at $0.05 as Price Action Remains FlatAccumulation Line - vinanet.vn
Ernexa Therapeutics (ERNA) Slips 2.2% to $4.17, Testing Key Support Amid Biotech PullbackCatalyst Driven Stocks - vinanet.vn
Ernexa Therapeutics (ERNA) Slips 0.7% to $4.27, Holds Above Key Support at $4.06Regression Channel - vinanet.vn
Ernexa Therapeutics Warrants (ERNAW) Surge 20% to $0.06 as Speculative Interest BuildsFibonacci Extension - vinanet.vn
Ernexa appoints David Polinsky to board ahead of IND filing By Investing.com - Investing.com Nigeria
Ernexa appoints David Polinsky to board ahead of IND filing - Investing.com
Ernexa Therapeutics Strengthens Board with Veteran Biotech - GlobeNewswire
Ernexa Therapeutics Strengthens Board with Veteran Biotech Executive David Polinsky as Company Approaches Clinical Stage - The Manila Times
Ernexa Therapeutics Inc expected to post a loss of $3.84 a shareEarnings Preview - TradingView
Ernexa Therapeutics (NASDAQ: ERNA) details $9.5M loss and cash strategy - Stock Titan
Tranche Update on Ernexa Therapeutics Inc.'s Equity Buyback Plan announced on November 25, 2024. - marketscreener.com
Price to sales forward of Ernexa Therapeutics Inc. – NASDAQ:ERNA - TradingView
Price to earnings forward of Ernexa Therapeutics Inc. – NASDAQ:ERNA - TradingView
Price to book forward of Ernexa Therapeutics Inc. – NASDAQ:ERNA - TradingView
Ernexa Therapeutics Inc. Revenue Breakdown – NASDAQ:ERNAW - TradingView
Ernexa Therapeutics Warrants (ERNAW) Hold Flat at $0.04 as Support and Resistance AlignCall Resistance - vinanet.vn
Ernexa Therapeutics (ERNA) Drops Nearly 5% as Bearish Pressure Builds Near Key SupportMarket Profile - dars.gov.et
Ernexa Therapeutics Inc. Revenue Breakdown – BOATS:ERNAW - TradingView
Ernexa Therapeutics Warrants (ERNAW) Slide 21.79% as Penny-Stock Volatility IntensifiesVolatility Surface - vinanet.vn
Ernexa Therapeutics Inc. (ERNA) stock price, news, quote and history - Yahoo Finance UK
Ernexa Therapeutics Inc. (ERNA) Stock Price, News, Quote & History - Yahoo! Finance Canada
Ernexa Therapeutics advances ERNA-101, a cell t... - Pluang
Ernexa Therapeutics CEO Corner Emphasizes How ERNA-101 - GlobeNewswire
Tumors cleared in about two-thirds of animals in ERNA-101 study - Stock Titan
Ernexa Therapeutics (ERNA) Q3 2023 Earnings: Clinical-Stage Biotech Reports Wider Loss as Pipeline AdvancesDividend Cut Risk - dars.gov.et
Ernexa's Innovative Approach to Cancer Treatment - Intellectia AI
Ernexa Therapeutics Warrants (ERNAW) Hold Steady at $0.07 as Trading Lacks DirectionAnalyst Upgrade Stocks - vinanet.vn
ERNA Q3 2023 Earnings: Loss Per Share Deepens, Stock Slides 16.39%Annual Earnings Summary - Vinanet
Ernexa Therapeutics Warrants (ERNAW) Hold Steady at $0.07: Minimal Price Action in Thin TradingRSI Overbought Alerts - vinanet.vn
Price to book forward of Ernexa Therapeutics Inc. – NASDAQ:ERNAW - TradingView
Ernexa Therapeutics Stock Climbs After Independent Study Validates ERNA-101 Tumor-Fighting Cell Therapy - Sahm
3 Most Active Penny Stocks to Watch Today, 7/16/2026 - TipRanks
ERNA Stock Whipsaws As Ernexa Maps Path To First Human Trial - StocksToTrade
Ernexa Therapeutics Inc Azioni (ERNA) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
3.04%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):